Skin and Induced Pluripotent Stem Cells As Biomarkers for Neurodegenerative Diseases

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2025 Jan 8

PMID 39766775

Authors

Efstathios Rallis

Vasiliki-Sofia Grech

Kleomenis Lotsaris

Niki Tertipi

Eleni Sfyri

Vassiliki Kefala

Affiliations

Soon will be listed here.

Abstract

As the global population ages, the rising prevalence of neurodegenerative diseases, characterized by abnormal protein aggregates, presents significant challenges for early diagnosis and disease monitoring. Identifying accessible tissue biomarkers is crucial for advancing our ability to detect and track the progression of these diseases. Among the most promising biomarkers is the skin, which shares a common embryological origin with the brain and central nervous system (CNS). This biological connection positions the skin as a potential reflection of CNS pathology. Over the past decades, gene expression studies have demonstrated that key genes involved in neurodegenerative diseases are also expressed in skin tissues. Genes such as , , , , , , , , and are prominent in this regard. Beyond gene expression, proteins related to neurodegenerative diseases-such as α-synuclein, TAU, PARKIN, and prion protein (PrP)-have been isolated from the skin of affected individuals, underscoring the skin's capacity to mirror neural degeneration. This non-invasive window into neurodegenerative processes is further enhanced by advances in stem cell technology, which have allowed for the generation of human-induced pluripotent stem cells (iPSCs) from patient-derived fibroblasts. These iPSCs offer a valuable model for studying disease mechanisms and developing therapeutic approaches. This review conducts a comprehensive analysis of the literature from databases such as PubMed, Google Scholar, and ResearchGate, emphasizing the unique potential of the skin as a non-invasive biomarker for neurodegenerative diseases. It explores how the skin serves as a bridge between gene expression and disease pathology in both the skin and the CNS. By leveraging this biological connection, the skin emerges as a promising model for enhancing our understanding of neurodegenerative disorders and developing innovative strategies for early detection and treatment. However, significant limitations remain, requiring further validation to establish the specificity and sensitivity of these biomarkers.

References

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

Park I, Lerou P, Zhao R, Huo H, Daley G . Generation of human-induced pluripotent stem cells. Nat Protoc. 2008; 3(7):1180-6. DOI: 10.1038/nprot.2008.92. View

Flinkman D, Hong Y, Gnjatovic J, Deshpande P, Ortutay Z, Peltonen S . Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson's disease. NPJ Parkinsons Dis. 2023; 9(1):20. PMC: 9902458. DOI: 10.1038/s41531-023-00460-w. View

Wang Z, Wu L, Gerasimenko M, Gilliland T, Shah Z, Lomax E . Seeding activity of skin misfolded tau as a biomarker for tauopathies. Mol Neurodegener. 2024; 19(1):92. PMC: 11606191. DOI: 10.1186/s13024-024-00781-1. View

Raman R, Allen S, Goodall E, Kramer S, Ponger L, Heath P . Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol Appl Neurobiol. 2014; 41(2):201-26. PMC: 4329387. DOI: 10.1111/nan.12147. View

Victor M, Richner M, Olsen H, Lee S, Monteys A, Ma C . Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat Neurosci. 2018; 21(3):341-352. PMC: 5857213. DOI: 10.1038/s41593-018-0075-7. View

Alvarez X, Franco A, Fernandez-Novoa L, Cacabelos R . Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease. Mol Chem Neuropathol. 1996; 29(2-3):237-52. DOI: 10.1007/BF02815005. View

Hermann P, Appleby B, Brandel J, Caughey B, Collins S, Geschwind M . Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021; 20(3):235-246. PMC: 8285036. DOI: 10.1016/S1474-4422(20)30477-4. View

Orru C, Yuan J, Appleby B, Li B, Li Y, Winner D . Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease. Sci Transl Med. 2017; 9(417). PMC: 5744860. DOI: 10.1126/scitranslmed.aam7785. View

10.

Bhinge A, Namboori S, Zhang X, VanDongen A, Stanton L . Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis. Stem Cell Reports. 2017; 8(4):856-869. PMC: 5390134. DOI: 10.1016/j.stemcr.2017.02.019. View

11.

Evangelisti C, Ramadan S, Orlacchio A, Panza E . Experimental Cell Models for Investigating Neurodegenerative Diseases. Int J Mol Sci. 2024; 25(17). PMC: 11396244. DOI: 10.3390/ijms25179747. View

12.

Marchina E, Misasi S, Bozzato A, Ferraboli S, Agosti C, Rozzini L . Gene expression profile in fibroblasts of Huntington's disease patients and controls. J Neurol Sci. 2013; 337(1-2):42-6. DOI: 10.1016/j.jns.2013.11.014. View

13.

Khalil Z, LoGiudice D, Khodr B, Maruff P, Masters C . Impaired peripheral endothelial microvascular responsiveness in Alzheimer's disease. J Alzheimers Dis. 2007; 11(1):25-32. DOI: 10.3233/jad-2007-11106. View

14.

Nagasaka Y, Dillner K, Ebise H, Teramoto R, Nakagawa H, Lilius L . A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings. Proc Natl Acad Sci U S A. 2005; 102(41):14854-9. PMC: 1253556. DOI: 10.1073/pnas.0504178102. View

15.

Wang Z, Becker K, Donadio V, Siedlak S, Yuan J, Rezaee M . Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol. 2020; . PMC: 7522783. DOI: 10.1001/jamaneurol.2020.3311. View

16.

Jameson C, Boulton K, Silove N, Nanan R, Guastella A . Ectodermal origins of the skin-brain axis: a novel model for the developing brain, inflammation, and neurodevelopmental conditions. Mol Psychiatry. 2022; 28(1):108-117. DOI: 10.1038/s41380-022-01829-8. View

17.

Zhao W, Feng C, Alkon D . Impairment of phosphatase 2A contributes to the prolonged MAP kinase phosphorylation in Alzheimer's disease fibroblasts. Neurobiol Dis. 2003; 14(3):458-69. DOI: 10.1016/s0969-9961(03)00124-4. View

18.

Wali G, Berkovsky S, Whiten D, Mackay-Sim A, Sue C . Single cell morphology distinguishes genotype and drug effect in Hereditary Spastic Paraplegia. Sci Rep. 2021; 11(1):16635. PMC: 8371156. DOI: 10.1038/s41598-021-95995-4. View

19.

Khan T, Alkon D . Peripheral biomarkers of Alzheimer's disease. J Alzheimers Dis. 2014; 44(3):729-44. DOI: 10.3233/JAD-142262. View

20.

Pitrez P, Monteiro L, Borgogno O, Nissan X, Mertens J, Ferreira L . Cellular reprogramming as a tool to model human aging in a dish. Nat Commun. 2024; 15(1):1816. PMC: 10902382. DOI: 10.1038/s41467-024-46004-5. View